Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis

OncoImmunology

Volumn 5, Issue 5, 2016, Pages

  Cottone, Lucia ^a,b   Capobianco, Annalisa ^a   Gualteroni, Chiara ^a   Monno, Antonella ^a   Raccagni, Isabella ^a,c   Valtorta, Silvia ^a,d   Canu, Tamara ^a   Di Tomaso, Tiziano ^e   Lombardo, Angelo ^b,e   Esposito, Antonio ^a,b   Moresco, Rosa Maria ^a,c   Del Maschio, Alessandro ^a,b   Naldini, Luigi ^b,e   Rovere Querini, Patrizia ^a,b   Bianchi, Marco E ^a,b   Manfredi, Angelo A ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d CNR   (Italy)

^e SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Alarmin; BoxA; Damage associated molecular pattern; DAMP; GFP; Green fluorescent protein; High mobility Box 1; HMGB1; Leukocytes; Macrophages; MC 38; Murine colon adenocarcinoma cell line; Peritoneal carcinomatosis; Short hairpin RNA; ShRNA; Vascularization

Indexed keywords

CLODRONIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOMATOUS PERITONITIS; CELL PROLIFERATION; CELL VIABILITY; CHEMOTAXIS ASSAY; COLON CARCINOMA; DISEASE COURSE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC MANIPULATION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM MACROPHAGE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; TUMOR GROWTH; VASCULARIZATION; WESTERN BLOTTING;

EID: 84965031845     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1122860     Document Type: Article

References (41)

1. M.D'Angelica, M.Gonen, M.F.Brennan, A.D.Turnbull, M.Bains, M.S.Karpeh. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004; 240:808-16; PMID:15492562; http://dx.doi.org/10.1097/01.sla.0000143245.28656.15
2. C.Kunisaki, H.Akiyama, M.Nomura, G.Matsuda, Y.Otsuka, H.Ono, Y.Nagahori, H.Hosoi, M.Takahashi, F.Kito et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol 2006; 13:659-67; PMID:16538414; http://dx.doi.org/10.1245/ASO.2006.07.015
3. A.Mantovani, A.Sica. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010; 22:231-7; PMID:20144856; http://dx.doi.org/10.1016/j.coi.2010.01.009
4. N.Erez, L.M.Coussens. Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization. Int J Cancer J Int du Cancer 2011; 128:2536-44; PMID:21387299; http://dx.doi.org/10.1002/ijc.26032
5. J.Galon, A.Costes, F.Sanchez-Cabo, A.Kirilovsky, B.Mlecnik, C.Lagorce-Pages, M.Tosolini, M.Camus, A.Berger, P.Wind et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi.org/10.1126/science.1129139
6. G.Sconocchia, I.Zlobec, A.Lugli, D.Calabrese, G.Iezzi, E.Karamitopoulou, E.S.Patsouris, G.Peros, M.Horcic, L.Tornillo et al. Tumor infiltration by FcgammaRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer 2011; 128:2663-72; PMID:20715106; http://dx.doi.org/10.1002/ijc.25609
7. M.R.Galdiero, E.Bonavita, I.Barajon, C.Garlanda, A.Mantovani, S.Jaillon. Tumor associated macrophages and neutrophils in cancer. Immunobiol 2013; 218:1402-10; PMID:23891329; http://dx.doi.org/10.1016/j.imbio.2013.06.003
8. L.Bosurgi, J.H.Bernink, V.Delgado Cuevas, N.Gagliani, L.Joannas, E.T.Schmid, C.J.Booth, S.Ghosh, C.V.Rothlin. Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer. Proc Natl Acad Sci U S A 2013; 110:13091-6; PMID:23878224; http://dx.doi.org/10.1073/pnas.1302507110
9. R.Noy, J.W.Pollard. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014; 41:49-61; PMID:25035953; http://dx.doi.org/10.1016/j.immuni.2014.06.010
10. R.Kang, Q.Zhang, H.J.Zeh, 3rd, M.T.Lotze, D.Tang. HMGB1 in cancer: good, bad, or both? Clin Cancer Res 2013; 19:4046-57; PMID:23723299; http://dx.doi.org/10.1158/1078-0432.CCR-13-0495
11. W.Li, K.Wu, E.Zhao, L.Shi, R.Li, P.Zhang, Y.Yin, X.Shuai, G.Wang, K.Tao. HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection. Biochem Biophys Res Commun 2013; 436:156-61; PMID:23707808; http://dx.doi.org/10.1016/j.bbrc.2013.04.109
12. M.E.Bianchi, A.A.Manfredi. How macrophages ring the inflammation alarm. Proc Natl Acad Sci U S A 2014; 111:2866-7; PMID:24532661; http://dx.doi.org/10.1073/pnas.1324285111
13. B.Lu, D.J.Antoine, K.Kwan, P.Lundback, H.Wahamaa, H.Schierbeck, M.Robinson, M.A.Van Zoelen, H.Yang, J.Li et al. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci U S A 2014; 111:3068-73; PMID:24469805; http://dx.doi.org/10.1073/pnas.1316925111
14. L.Cottone, A.Capobianco, C.Gualteroni, C.Perrotta, M.E.Bianchi, P.Rovere-Querini, A.A.Manfredi. 5-Fluorouracil causes leukocytes attraction in the peritoneal cavity by activating autophagy and HMGB1 release in colon carcinoma cells. Int J Cancer 2015; 136:1381-9; PMID:25098891; http://dx.doi.org/10.1002/ijc.29125
15. A.Capobianco, A.Monno, L.Cottone, M.A.Venneri, D.Biziato, F.Di Puppo, S.Ferrari, M.De Palma, A.A.Manfredi, P.Rovere-Querini. Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J Pathol 2011; 179:2651-9; PMID:21924227; http://dx.doi.org/10.1016/j.ajpath.2011.07.029
16. M.Y.K.S.Fong. Ovarian cancer mouse models: A summary of current models and their limitations. J Ovarian Res 2009; 2(1):12; PMID:19781107; http://dx.doi.org/10.1186/1757-2215-2-12
17. E.K.Colvin, C.J.Scarlett. A historical perspective of pancreatic cancer mouse models. Semin Cell Dev Biol 2014; 27:96-105; PMID:24685616; http://dx.doi.org/10.1016/j.semcdb.2014.03.025
18. S.A.Rosenberg, P.Spiess, R.Lafreniere. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986; 233:1318-21; PMID:3489291; http://dx.doi.org/10.1126/science.3489291
19. T.M.Robinson-Smith, I.Isaacsohn, C.A.Mercer, M.Zhou, N.Van Rooijen, N.Husseinzadeh, M.M.McFarland-Mancini, A.F.Drew. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res 2007; 67:5708-16; PMID:17575137; http://dx.doi.org/10.1158/0008-5472.CAN-06-4375
20. M.Rei, N.Goncalves-Sousa, T.Lanca, R.G.Thompson, S.Mensurado, F.R.Balkwill, H.Kulbe, D.J.Pennington, B.Silva-Santos. Murine CD27(-) Vgamma6(+) gammadelta T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc Natl Acad Sci U S A 2014; 111:E3562-70; PMID:25114209; http://dx.doi.org/10.1073/pnas.1403424111
21. E.K.Colvin. Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol 2014; 4:137; PMID:24936477; http://dx.doi.org/10.3389/fonc.2014.00137
22. M.Bacci, A.Capobianco, A.Monno, L.Cottone, F.Di Puppo, B.Camisa, M.Mariani, C.Brignole, M.Ponzoni, S.Ferrari et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 2009; 175:547-56; PMID:19574425; http://dx.doi.org/10.2353/ajpath.2009.081011
23. A.Capobianco, P.Rovere-Querini. Endometriosis, a disease of the macrophage. Front Immunol 2013; 4:9; PMID:23372570; http://dx.doi.org/10.3389/fimmu.2013.00009
24. J.Segelman, F.Granath, T.Holm, M.Machado, H.Mahteme, A.Martling. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 2012; 99:699-705; PMID:22287157; http://dx.doi.org/10.1002/bjs.8679
25. M.J.Koppe, O.C.Boerman, W.J.Oyen, R.P.Bleichrodt. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243:212-22; PMID:16432354; http://dx.doi.org/10.1097/01.sla.0000197702.46394.16
26. D.A.Sloothaak, B.Mirck, C.J.Punt, W.A.Bemelman, J.D.van der Bilt, A.D'Hoore, P.J.Tanis. Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review. Br J Cancer 2014; 111:1112-21; PMID:25025964; http://dx.doi.org/10.1038/bjc.2014.369
27. M.Schiraldi, A.Raucci, L.M.Munoz, E.Livoti, B.Celona, E.Venereau, T.Apuzzo, F.De Marchis, M.Pedotti, A.Bachi et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012; 209:551-63; PMID:22370717; http://dx.doi.org/10.1084/jem.20111739
28. E.Venereau, M.Schiraldi, M.Uguccioni, M.E.Bianchi. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol 2013; 55:76-82; PMID:23207101; http://dx.doi.org/10.1016/j.molimm.2012.10.037
29. H.Yang, D.J.Antoine, U.Andersson, K.J.Tracey. The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol 2013; 93:865-73; PMID:23446148; http://dx.doi.org/10.1189/jlb.1212662
30. Y.Liu, W.Yan, S.Tohme, M.Chen, Y.Fu, D.Tian, M.Lotze, D.Tang, A.Tsung. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll Like Receptor 9. J Hepatol 2015; 63(1):114-21; PMID:25681553; http://dx.doi.org/10.1016/j.jhep.2015.02.009
31. H.Yang, Z.Rivera, S.Jube, M.Nasu, P.Bertino, C.Goparaju, G.Franzoso, M.T.Lotze, T.Krausz et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A 2010; 107:12611-6; PMID:20616036; http://dx.doi.org/10.1073/pnas.1006542107
32. F.Qi, G.Okimoto, S.Jube, A.Napolitano, H.I.Pass, R.Laczko, R.M.Demay, G.Khan, M.Tiirikainen, C.Rinaudo et al. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling. Am J Pathol 2013; 183:1654-66; PMID:24160326; http://dx.doi.org/10.1016/j.ajpath.2013.07.029
33. S.Jube, Z.S.Rivera, M.E.Bianchi, A.Powers, E.Wang, I.Pagano, H.I.Pass, G.Gaudino, M.Carbone, H.Yang. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. Cancer Res 2012; 72:3290-301; PMID:22552293; http://dx.doi.org/10.1158/0008-5472.CAN-11-3481
34. J.E.Ellerman, C.K.Brown, M.de Vera, H.J.Zeh, T.Billiar, A.Rubartelli, M.T.Lotze. Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 2007; 13:2836-48; PMID:17504981; http://dx.doi.org/10.1158/1078-0432.CCR-06-1953
35. L.Campana, F.Santarella, A.Esposito, N.Maugeri, E.Rigamonti, A.Monno, T.Canu, A.Del Maschio, M.E.Bianchi, A.A.Manfredi et al. Leukocyte HMGB1 Is Required for Vessel Remodeling in Regenerating Muscles. J Immunol 2014; 192:5257-64; PMID:24752445; http://dx.doi.org/10.4049/jimmunol.1300938
36. P.Rovere-Querini, A.Capobianco, P.Scaffidi, B.Valentinis, F.Catalanotti, M.Giazzon, I.E.Dumitriu, S.Müller, M.Iannacone, C.Traversari et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004; 5:825-30; PMID:15272298; http://dx.doi.org/10.1038/sj.embor.7400205
37. M.Amendola, L.Passerini, F.Pucci, B.Gentner, R.Bacchetta, L.Naldini. Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform. Mol Ther 2009; 17:1039-52; PMID:19293777; http://dx.doi.org/10.1038/mt.2009.48
38. A.Cantore, M.Ranzani, C.C.Bartholomae, M.Volpin, P.D.Valle, F.Sanvito, L.S.Sergi, P.Gallina, F.Benedicenti, D.Bellinger et al. Liver-directed lentiviral gene therapy in a dog model of hemophilia B. Sci Transl Med 2015; 7:277ra28; PMID:25739762; http://dx.doi.org/10.1126/scitranslmed.aaa1405
39. A.A.Manfredi, A.Capobianco, A.Esposito, F.De Cobelli, T.Canu, A.Monno, A.Raucci, F.Sanvito, C.Doglioni, P.P.Nawroth et al. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 2008; 180:2270-5; PMID:18250435; http://dx.doi.org/10.4049/jimmunol.180.4.2270
40. L.Campana, L.Bosurgi, M.E.Bianchi, A.A.Manfredi, P.Rovere-Querini. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukocyte Biol 2009; 86:609-15; PMID:19414537; http://dx.doi.org/10.1189/jlb.0908576
41. L.Cottone, S.Valtorta, A.Capobianco, S.Belloli, P.Rovere-Querini, F.Fazio, A.A.Manfredi, R.M.Moresco. Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET. J Nuclear Med 2011; 52:1770-7; PMID:22045707; http://dx.doi.org/10.2967/jnumed.111.089177